Apogee Therapeutics

Company snapshot

Apogee Therapeutics is a biotechnology company advancing novel, potentially best-in-class therapies to address the needs of the millions of people living with immunological and inflammatory disorders.

• 8 active pipeline program(s) linked via ClinicalTrials.gov.
• 7 US patent(s) indexed to this assignee profile.
• 8 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for Apogee Therapeutics. Not investment advice.

• Peer + 0 momentum

  GSK Glaxo Smith

  TA overlap score 40

• Peer + 0 momentum

  Regeneron UK

  TA overlap score 40

• Peer + 0 momentum

  Teva Pharma

  TA overlap score 40

• Peer + 0 momentum

  Samsung Bioepis

  TA overlap score 24.8

• Peer + 0 momentum

  CASI Pharmaceuticals

  TA overlap score 24.4

• Peer + 0 momentum

  MedImmune

  TA overlap score 21.8

• Peer + 0 momentum

  Corvus Pharmaceuticals

  TA overlap score 21.8

• Peer + 0 momentum

  Teva/Actavis Generics

  TA overlap score 20.8

Recent activity

Latest pipeline, patent, and corporate events for Apogee Therapeutics.

1. Jun 5, 2026 Clinical update

   APG777, Placebo — Phase 2

2. Jun 5, 2026 Clinical update

   Placebo, APG777 — Phase 2

3. Jun 5, 2026 Clinical update

   sphingosine kinase-2 inhibitor ABC294640 — Phase 1

4. May 23, 2026 Clinical update

   ABC294640 — Phase 2

5. May 23, 2026 Clinical update

   ABC294640 — Phase 2

View all clinical trial activity →

• What is Apogee Therapeutics?

  Apogee Therapeutics is a biotech organization headquartered in WALTHAM, MA, USA. It trades on NYSE under ticker APGE. Primary therapeutic focus areas include Atopic Dermatitis, Asthma, Carcinoma, Hepatocellular, Diffuse Large B Cell Lymphoma, Multiple Myeloma. NovaPharmaNews link

• Is Apogee Therapeutics publicly traded?

  Yes. Apogee Therapeutics is listed with ticker APGE on NYSE per SEC EDGAR records linked on this profile.

• What drugs does Apogee Therapeutics develop or market?

  We link 2 drug profile(s) where Apogee Therapeutics is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/apogee-therapeutics#company-drugs.

• What are the latest developments for Apogee Therapeutics?

  In the last 12 months our linked public records show 8 trial program update(s) and 3 US patent grant(s) tied to this profile.

• What therapeutic areas does Apogee Therapeutics focus on?

  Apogee Therapeutics focuses on Atopic Dermatitis, Asthma, Carcinoma, Hepatocellular based on our analysis of their pipeline programs and drug development activities.